How to appeal a Xolair denial
The short answer
Xolair denials usually turn on prior-authorization criteria: an allergy blood test or skin test, an IgE level in range, months of inhaled steroids plus another controller for asthma, or high-dose antihistamines for hives. Get your plan's written criteria and have your doctor send the matching test results and treatment history with dates.
- StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
- Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
- Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.
Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.
What Xolair is approved for
Xolair (omalizumab) is an anti-IgE antibody. As of November 2026 its FDA label lists four uses:
- Moderate to severe persistent allergic asthma in people 6 and older whose symptoms are not controlled with inhaled steroids and who test positive to a year-round airborne allergen.
- Chronic rhinosinusitis with nasal polyps in adults, as add-on treatment.
- IgE-mediated food allergy in people 1 and older, to reduce reactions from accidental exposure.
- Chronic spontaneous urticaria (hives) in people 12 and older who still have symptoms on antihistamines.
Why plans deny Xolair
One insurer's policy says prior authorization is required for Xolair. For asthma it asks for:
- A baseline IgE level of at least 30 IU/mL.
- A positive skin or blood test to an airborne allergen.
- At least 3 consecutive months of a medium- or high-dose inhaled steroid plus another controller medicine.
- Asthma that stays uncontrolled, such as two or more flares needing oral steroids in the past year.
- Lung function tests showing asthma.
For hives, it asks for hives lasting 6 weeks or more and a trial of high-dose second-generation antihistamines. Denials often come from a missing lab value or undated medication history.
Reading the denial
Job-based plans must name the specific plan provision behind a denial, and you can ask for a free copy of the criteria. "Criteria not met" means the plan wanted more medical proof; see prior authorization denials. "Step therapy" or "try a preferred product first" means the plan wants another drug tried; see step therapy denials. "Non-formulary" means Xolair is not on the drug list, which calls for a formulary exception. Check your plan's drug list to see what it prefers.
What your doctor's letter should document
Ask for a letter of medical necessity that answers each criterion, in order, with dated records:
- The diagnosis and its diagnosis code.
- IgE level and allergy test results, with dates taken before any biologic.
- Lung function results for asthma.
- Each asthma or hives medicine tried, with doses and dates.
- Flares, emergency visits or oral steroid courses in the past year.
- For renewals, specific improvement since starting Xolair.
Ask the plan for the written criteria it used. Job-based plans must name the specific plan provision behind a denial and give you a free copy of any criteria they relied on. File the internal appeal within 180 days of the denial.
If Xolair is not on the drug list, ask for a formulary exception instead of, or alongside, the appeal. Your doctor generally confirms that covered drugs have not worked, will not work as well, or are likely to cause harm. Individual and small-group plans must decide a standard request within 72 hours and an expedited one within 24 hours, and a denial can go to an independent reviewer. See formulary exception letters.
If the plan upholds a denial that turned on medical judgment, you can ask for external review within 4 months of the final decision. Your insurer has to accept the reviewer’s decision.
Medicare, Medicaid and manufacturer help
With a Medicare drug plan, ask for a coverage determination or exception. Your prescriber must provide a statement explaining the medical reason. The plan must decide within 72 hours, or 24 hours if expedited, and Part D exceptions can also cover step therapy and dose limits. You have 65 days to appeal a denial. See Part D appeals.
When a clinic gives the drug, Medicare may pay under Part B instead. Medicare.gov says Part B usually covers drugs you wouldn’t typically give to yourself, like those given in a doctor's office, and most injectable and infused drugs when a licensed provider gives them. Ask the clinic which part of Medicare it is billing, because the appeal path differs. See Original Medicare appeals.
State Medicaid programs may require prior authorization for any covered drug. See Medicaid appeals.
Genentech says people who cannot afford Xolair may be eligible for help through the Genentech Patient Foundation.
Questions people ask
What IgE level does insurance need for Xolair?
It varies by plan and condition. One policy's asthma criteria ask for a baseline IgE of at least 30 IU/mL, measured before any drug that lowers IgE.
Why was Xolair denied for hives?
Check whether the request showed hives for at least 6 weeks and a trial of high-dose antihistamines. Have your doctor document the antihistamine, dose and dates.
Insurance stopped covering Xolair after I'd been on it. What can I do?
First find out why: a lapsed prior authorization, a renewal that asked for proof the drug is working, or a drug-list change. Ask your doctor to resubmit with current records. In individual and small-group plans, being in the middle of a course of treatment on a non-formulary drug qualifies for a 24-hour expedited exception. Medicare drug plans must offer a temporary supply in the first 90 days under a new plan, and that process also covers current enrollees affected by formulary changes.
What if my Xolair appeal is denied?
If the denial turned on medical judgment, you can ask for external review by an independent reviewer within 4 months of the plan's final decision. A denied formulary exception in an individual or small-group plan can also go to independent review. With Medicare Part D, if the plan upholds its denial you have 60 days to ask a Part D Independent Review Entity to reconsider; see Part D appeals.
Sources
- National Library of Medicine (DailyMed): XOLAIR (omalizumab) prescribing information (DailyMed)
XOLAIR is an anti-IgE antibody indicated for:
- Cigna Healthcare: Drug Coverage Policy IP0487: Omalizumab (Xolair) (effective 7/15/2026)
Prior Authorization is required for benefit coverage of Xolair.
- eCFR (Office of the Federal Register): 29 CFR 2560.503-1 -- Claims procedure
Reference to the specific plan provisions on which the determination is based
- HealthCare.gov: Getting prescription medications
Visit your insurer’s website to review a list of prescriptions your plan covers
- HealthCare.gov: Internal appeals
You must file your internal appeal within 180 days (6 months) of receiving notice that your claim was denied.
- eCFR (Office of the Federal Register): 45 CFR 156.122 -- Prescription drug benefits
A health plan must make its determination on a standard exception and notify the enrollee or the enrollee's designee and the prescribing physician (or other prescriber, as appropriate) of its coverage determination no later than 72 hours following receipt of the request.
- HealthCare.gov: External Review
You must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
- Medicare.gov: Appeals in a Medicare drug plan
If you're asking for an exception, your prescriber must provide a statement explaining the medical reason why the exception should be approved.
- eCFR (Office of the Federal Register): 42 CFR 423.568 -- Standard timeframe and notice requirements for coverage determinations
but no later than 72 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.572 -- Timeframes and notice requirements for expedited coverage determinations
but no later than 24 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.578 -- Exceptions process
An exception to a plan's coverage policy that causes a Part D prescription drug not to be covered because of cost utilization tools, such as a requirement for step therapy, dosage limitations, or therapeutic substitution.
- Legal Information Institute, Cornell Law School: 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugs
A State may subject to prior authorization any covered outpatient drug
- Medicare.gov: Prescription drugs (outpatient)
Usually, Part B covers drugs you wouldn't typically give to yourself, like those you get at a doctor's office or in a hospital outpatient setting.
- Genentech: XOLAIR cost
If you are unable to afford XOLAIR, you may be eligible for additional assistance through the Genentech Patient Foundation.
- eCFR (Office of the Federal Register): 42 CFR 423.120 -- Access to covered Part D drugs
Ensure access to a temporary supply of drugs within the first 90 days of coverage under a new plan.
This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.